5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine

C90H103Br3Cl7N21 — CID 160889942

IUPAC5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine
SMILESCN(C)CCCNc1nc(CN2CCN(C(c3cc(Cl)cc(Cl)c3)c3ccc(Br)cn3)CC2)nc2ccccc12.CN(C)CCCNc1nc(CN2CCN(C(c3cc(Cl)cc(Cl)c3)c3ccc(Br)cn3)CC2)nc2ccccc12.CN(C)CCCNc1nc(CN2CCNCC2)nc2ccccc12.Clc1cc(Cl)cc(C(Cl)c2ccc(Br)cn2)c1
InChIInChI=1S/2C30H34BrCl2N7.C18H28N6.C12H7BrCl3N/c2*1-38(2)11-5-10-34-30-25-6-3-4-7-26(25)36-28(37-30)20-39-12-14-40(15-13-39)29(27-9-8-22(31)19-35-27)21-16-23(32)18-24(33)17-21;1-23(2)11-5-8-20-18-15-6-3-4-7-16(15)21-17(22-18)14-24-12-9-19-10-13-24;13-8-1-2-11(17-6-8)12(16)7-3-9(14)5-10(15)4-7/h2*3-4,6-9,16-19,29H,5,10-15,20H2,1-2H3,(H,34,36,37);3-4,6-7,19H,5,8-14H2,1-2H3,(H,20,21,22);1-6,12H
InChIKeySODBPPKJPKBBIR-UHFFFAOYSA-N
MW1966.84 g/mol
LogP19.61
Rot. Bonds29

About 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine

5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine (PubChem CID 160889942) has the molecular formula C90H103Br3Cl7N21 and a molecular weight of 1966.84 g/mol. Its IUPAC name is 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine.

Molecular Properties

Compound Name5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine
PubChem CID160889942
Molecular FormulaC90H103Br3Cl7N21
Molecular Weight1966.84 g/mol
Exact Mass1959.41
IUPAC Name5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine
SMILESCN(C)CCCNc1nc(CN2CCN(C(c3cc(Cl)cc(Cl)c3)c3ccc(Br)cn3)CC2)nc2ccccc12.CN(C)CCCNc1nc(CN2CCN(C(c3cc(Cl)cc(Cl)c3)c3ccc(Br)cn3)CC2)nc2ccccc12.CN(C)CCCNc1nc(CN2CCNCC2)nc2ccccc12.Clc1cc(Cl)cc(C(Cl)c2ccc(Br)cn2)c1
InChIInChI=1S/2C30H34BrCl2N7.C18H28N6.C12H7BrCl3N/c2*1-38(2)11-5-10-34-30-25-6-3-4-7-26(25)36-28(37-30)20-39-12-14-40(15-13-39)29(27-9-8-22(31)19-35-27)21-16-23(32)18-24(33)17-21;1-23(2)11-5-8-20-18-15-6-3-4-7-16(15)21-17(22-18)14-24-12-9-19-10-13-24;13-8-1-2-11(17-6-8)12(16)7-3-9(14)5-10(15)4-7/h2*3-4,6-9,16-19,29H,5,10-15,20H2,1-2H3,(H,34,36,37);3-4,6-7,19H,5,8-14H2,1-2H3,(H,20,21,22);1-6,12H
InChIKeySODBPPKJPKBBIR-UHFFFAOYSA-N
XLogP19.61
TPSA190.05 Ų
H-Bond Donors4
H-Bond Acceptors21
Rotatable Bonds29
Heavy Atoms121
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001966.84
LogP ≤ 519.61
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine?
The IUPAC name of 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine (CID 160889942) is 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine.
What is the SMILES notation for 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine?
The canonical SMILES for 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine is CN(C)CCCNc1nc(CN2CCN(C(c3cc(Cl)cc(Cl)c3)c3ccc(Br)cn3)CC2)nc2ccccc12.CN(C)CCCNc1nc(CN2CCN(C(c3cc(Cl)cc(Cl)c3)c3ccc(Br)cn3)CC2)nc2ccccc12.CN(C)CCCNc1nc(CN2CCNCC2)nc2ccccc12.Clc1cc(Cl)cc(C(Cl)c2ccc(Br)cn2)c1.
What is the InChIKey of 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine?
The InChIKey is SODBPPKJPKBBIR-UHFFFAOYSA-N. The full InChI is InChI=1S/2C30H34BrCl2N7.C18H28N6.C12H7BrCl3N/c2*1-38(2)11-5-10-34-30-25-6-3-4-7-26(25)36-28(37-30)20-39-12-14-40(15-13-39)29(27-9-8-22(31)19-35-27)21-16-23(32)18-24(33)17-21;1-23(2)11-5-8-20-18-15-6-3-4-7-16(15)21-17(22-18)14-24-12-9-19-10-13-24;13-8-1-2-11(17-6-8)12(16)7-3-9(14)5-10(15)4-7/h2*3-4,6-9,16-19,29H,5,10-15,20H2,1-2H3,(H,34,36,37);3-4,6-7,19H,5,8-14H2,1-2H3,(H,20,21,22);1-6,12H.
What are the key properties of 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine?
5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine has a molecular weight of 1966.84 g/mol, XLogP of 19.61, 29 rotatable bonds, 4 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-2-[chloro-(3,5-dichlorophenyl)methyl]pyridine;bis(N-[2-[[4-[(5-bromo-2-pyridinyl)-(3,5-dichlorophenyl)methyl]piperazin-1-yl]methyl]quinazolin-4-yl]-N',N'-dimethylpropane-1,3-diamine);N',N'-dimethyl-N-[2-(piperazin-1-ylmethyl)quinazolin-4-yl]propane-1,3-diamine is sourced from PubChem (CID 160889942), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).